ALFA Finder| Execution period | 3 years |
|---|
BSE filing, BSE: 544365. Summary written from the filing by ALFA Finder's alert engine.
Shanmuga Hospital Ltd: key numbers
- Share price
- ₹45.00
- Market cap
- ₹61.26 Cr
- Revenue (annual)
- ₹47.44 Cr
- Net profit (annual)
- ₹4.21 Cr
- P/E (TTM)
- 14.6×Sector 54.5×
- Promoter holding
- 72.35%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shanmuga Hospital Ltd
All →Shanmuga Hospital Board Meeting Date
Shanmuga Hospital Limited will hold a board meeting on 12 November 2026 to consider unaudited standalone half-year results for September 2026 and an interim dividend. Trading window closes from 1 October 2026.
Shanmuga Hospital Product Launch
Shanmuga Hospital commercially launched its 'Shanmuga 360' healthcare mobile app on 20 October 2026. It offers medicine booking, lab tests, ambulance and home-care services.
Shanmuga Hospital Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory norms.
Shanmuga Hospital Capital Structure Change
Shanmuga Hospital's members approved an increase in authorized share capital from ₹14 Crore to ₹25 Crore at the 6th Annual General Meeting.
Shanmuga Hospital Other Announcement
Shanmuga Hospital Limited appointed CS S Anuradha as the Secretarial Auditor for a five-year term starting from FY 2026-27.
- Execution
- 5 years (FY 2026-27 to FY 2030-31)
Shanmuga Hospital Management Change
Shanmuga Hospital Limited has appointed Mrs. S Anuradha as the new Secretarial Auditor. The appointment is for a term of 60 months.
Other business update announcements
All →Suven Life Sciences Business Update
Suven Life Sciences will present seven posters on its CNS pipeline at Neuroscience 2026, Washington DC. Presentations span Phase-3 and preclinical candidates targeting neurodegenerative and neuropsychiatric disorders.
Smruthi Organics Business Update
Smruthi Organics received the Brazilian GMP (CBPF) certificate for its Unit II API, Levamlodipine Besylate Hemi pentahydrate. This strengthens its regulatory presence in the Brazilian pharmaceutical market.
Kreon Finnancial Services Business Update
Kreon Financial Services launched StuCred for Startups, a mentorship initiative for student entrepreneurs. No revenue projection or monetary value is attached to the new program.
Aurobindo Pharma Business Update
Aurobindo Pharma disclosed that US FDA classified its Lannett facility inspection as Official Action Indicated (OAI). The company states there is no quantifiable financial or operational impact.
Gokaldas Exports Business Update
Gokaldas Exports issued a press release clarifying a customer's Chapter 11 filing, which involves USD 4.11 million of receivables held by its African subsidiary Atraco. It also reports two new customers onboarded in its African operations.
Adani Enterprises Business Update
Adani Enterprises' Kutch Copper became the first Indian producer to receive the Copper Mark certification. It recognises responsible copper production under independent ESG audits.